LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology ...
10h
Investing in America Series: Los Angeles confronts its cost, climate and competitiveness challenges
America’s second-largest city is balancing booming sectors and world-class talent with rising inequality, strained ...
Veligrotug BLA accepted for thyroid eye disease (TED) with PDUFA target action date of June 30, 2026 under Priority Review; commercial preparations on track -- Topline phase 3 results for subcutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback